Allogeneic Skin Grafts for Burns: Challenges of Rejection and Infection

Allogeneic (donor) skin grafts for burn patients face significant hurdles:

1. Immunological Rejection

Recipient's immune system recognizes donor HLA antigens → cytotoxic T-cell response → graft destruction. Requires immunosuppression (risky in burn patients).

2. Infection Transmission Risk

Viruses (HIV, HCV, HBV, CMV), bacteria, fungi. Screening reduces but doesn't eliminate risk.

3. Limited Availability

Donor skin scarce; HLA matching further restricts supply. Skin banks help but cannot meet acute massive burn needs.

4. Ethical Concerns

Consent, procurement equity, potential exploitation of vulnerable donors.

5. Surgical Complexity

Technically demanding; risks of bleeding, infection, scarring, contracture.

Current Standard

Autologous grafts (patient's own skin) are gold standard—no rejection, lower infection risk. Allogeneic/xenogeneic grafts or synthetic/biologic temporizing matrices (e.g., Integra) are used as temporary coverage until autograft sites heal for reharvest.

Burns - Related Articles